Gene Green: “Title VIII programs have long enjoyed bipartisan support, and I am glad that it has continued with the introduction of…”

While were a still great success in the last decade, the sun doesn't always shine and the wind doesn't always blow.

The Cures Act aimed to build on the progress of the HITECH Act of 2009, but by focusing on improving interoperability, patient access to their health records, and reducing provider burden.

I am extremely disappointed that 2 years after the passage of Cures we still do not have the regulations necessary to implement these provisions.

The 340B Drug Pricing Program was created by Congress in 1992. It helps safety net providers care for their most vulnerable patients and afford drugs that would otherwise be out of reach.